Mylan's Copaxone Suit Against Teva Should Survive, Judge Says
Teva Pharmaceutical Industries Ltd.'s bid to dismiss antitrust claims should be denied in a case where Mylan Pharmaceuticals Inc. alleges the company unlawfully delayed a generic version of a multiple ...
S&P 500 February winners, losers as stock benchmark ends monthly journey in the red
The S&P 500 (SP500) hit new highs during February trade, but that wasn’t enough to stave off a monthly loss. The benchmark ...
Bronstein, Gewirtz & Grossman, LLC Encourages Corcept Therapeutics Incorporated (CORT) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / February 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...
Teva Pharmaceutical: A Risky Bet With Potential Upside
Teva's stock is a speculative buy with potential upside if biosimilars succeed, but risks remain high due to debt and ...
Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?
We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...
Can't wait for Hoka's adventure sandal to be released? Teva's new technical Grandview Max has arrived, and it's ready to tackle the trails
Yes, we know, it's still February and yet we can't stop going on about hiking sandals, but what can we say? Our toes are ...
FDA accepts Teva & Medincell’s UZEDY sNDA for extended-release to treat BP-I
Teva Pharmaceuticals (TEVA) and Medincell (MEDCL) announced that the supplemental New Drug Application sNDA for UZEDY extended-release ...
Teva’s New Max-Cushioned Hiking Sandal Puts Hoka on Notice
Backed by 40-plus years of experience, the new Grandview Max stakes it claim as this spring's open-toed outdoor overlord.
ophthalmologytimes3d
UK MHRA issues approval for aflibercept biosimilar FYB203 (AHZANTIVE) from Formycon
FYB203, a biosimilar to aflibercept, received UK MHRA approval for multiple retinal conditions and will be marketed as ...